American Society of Hematology

Fig. 3.

$Fig. 3. Donor cell engraftment in growth factor–pretreated recipients of transplants. / Percentage of donor-derived leukocytes in peripheral blood of sublethally (4 Gy) irradiated host mice after transplantation of 3.0 × 106 unfractionated donor bone marrow cells. Recipient mice were treated with growth factors for 1 day (closed symbols) or 7 days (open symbols) before irradiation. Mice treated with SCF plus IL-11, SCF plus FL, and G-CSF are depicted in panels A, B, and C, respectively. Each line represents the mean ± SEM of 2 independent experiments (n = 4 per experiment).$

Donor cell engraftment in growth factor–pretreated recipients of transplants.

Percentage of donor-derived leukocytes in peripheral blood of sublethally (4 Gy) irradiated host mice after transplantation of 3.0 × 10⁶ unfractionated donor bone marrow cells. Recipient mice were treated with growth factors for 1 day (closed symbols) or 7 days (open symbols) before irradiation. Mice treated with SCF plus IL-11, SCF plus FL, and G-CSF are depicted in panels A, B, and C, respectively. Each line represents the mean ± SEM of 2 independent experiments (n = 4 per experiment).

This Feature Is Available To Subscribers Only